Severin Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Sell
10,464
-1,409
-12% -$165K 1.01% 20
2026
Q1
$1.43M Sell
11,873
-590
-5% -$68.1K 1.23% 11
2025
Q4
$1.31M Sell
12,463
-5
-0% -$469 1.16% 11
2025
Q3
$1.05M Buy
12,468
+7,274
+140% +$599K 0.93% 21
2025
Q2
$411K Sell
5,194
-3,914
-43% -$311K 0.39% 113
2025
Q1
$817K Buy
9,108
+286
+3% +$26.7K 0.82% 22
2024
Q4
$878K Buy
+8,822
New +$910K 0.87% 21

Other funds holding MRK

Severin Investments's MRK Position: Q2 2026 in Review

Severin Investments reduced its Merck (MRK) stake by 12% in Q2 2026, selling an estimated $165K and leaving 10,464 shares worth $1.34M. The position accounts for 1.01% of the portfolio, ranked #20.

Severin Investments first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.43M in Q1 2026. 3,814 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Severin Investments held 10,464 shares of Merck worth $1.34M as of Q2 2026.
  • Severin Investments sold 1,409 Merck shares in Q2 2026, an estimated $165K.
  • Merck made up 1.01% of Severin Investments's portfolio in Q2 2026, its #20 holding.
  • Severin Investments first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Severin Investments's Merck position peaked at $1.43M in Q1 2026.
  • 3,814 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Severin Investments's 13F filing for Q2 2026, filed 14 Aug 2026.